TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improved performance of the non‐dominant hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ET(CO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central venous hydrogen ion concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain at rest during POD1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid consumption on POD1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee Extension Strength (KES) on POD1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hedonic ratings of food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rewarding value of food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive and behavioural effects
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: survival rates without clinical failure
Endpoint domain: Mortality/survival
Primary endpoint: occurrence of unfavourable pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for postoperative interventions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Restenosis/occlusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated FSO diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in ISI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in circadian functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BPF decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of ER visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean number of clinic visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Overall microbiological profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient enablement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preference for FF/VI treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: percentage of experimental network members reporting unprotected intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage who engaged in unprotected intercourse with multiple partners
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aqueous humour levels of ciprofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitreous humour levels of ciprofloxacin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usage of TCRB VJ gene-segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: major technical mistakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minor technical mistakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative duration of mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative plasma lactate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of simple endometrial hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of estrogen receptors in glandular epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of Ki-67 antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of LVO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endocardial border visualized
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma nitrite concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of Candida spp. counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Flexural strength (in MPa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse of Crohn's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: end of the day comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: lens feeling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: occlusion rate of atherosclerotic radial arteries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: postcannulation complications
Endpoint domain: Adverse events/effects
Primary endpoint: mean time for return to normal diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Root mean square electromyography (rmsEMG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mean power frequency (MPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Test-retest reliability of the Rome criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute glucose-stimulated insulin response (GSIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: decorin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late GI toxicity grade > or =2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Late GU toxicity grade > or =2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Genitourinary outcomes
Primary endpoint: Late rectal bleeding requiring treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Rise in intraocular pressure (IOP)
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of SEIs
Endpoint domain: Adverse events/effects
Primary endpoint: Primary patency at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Freedom from CD‐TVR at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ABI improvement at 9 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Freedom from atrial flutter at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacokinetics of olanzapine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effects of olanzapine
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in peak aerobic capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician-Administered PTSD Scale-Child and Adolescent Version
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reepithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to predetermined resuscitation tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crisis resource management performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-segment late loss (LL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemia-driven target vessel failure (TVF)
Endpoint domain: Mortality/survival
Primary endpoint: gap measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: implant long-term survival
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in Nerve Sensory Conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in Nerve Sensory Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reduction in distal emboli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melanin index improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: communication success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: melanoma risk
Endpoint domain: Mortality/survival
Primary endpoint: tumor thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clark levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of remitters (MADRS ≤ 12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental side effects
Endpoint domain: Adverse events/effects
Primary endpoint: mean supine minus mean upright PaO2 (dPaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Application of telemedicine in diabetes foot ulcer follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall cosmesis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of IGT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-h glucose levels during OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: restoring time of enterokinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: time of first exsufflation from the anus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: breast-feeding rate at 42 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically significant PSFS scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Physiotherapist performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPPCs at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative in‐hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of contralateral breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: negative axillary status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Forearm blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Degree of postictal suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Seizure induction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: HOMA‐β C‐peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: specific osteosynthesis-caused complications
Endpoint domain: Adverse events/effects
Primary endpoint: wound-healing impairments
Endpoint domain: Adverse events/effects
Primary endpoint: cut-out rate
Endpoint domain: Adverse events/effects
Primary endpoint: Posttreatment ambulatory rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diminished survival predicted by baseline serum IL-6
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of NRS for spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: faecal bifidobacteria enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: SGA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: number of hospitalization days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: complete healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: return of normal sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean difference in vegetable intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P2 amplitude during the dot-probe task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depression vulnerability to a post-training stressor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated GFR improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: asthma self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-perceived coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Transferrin saturation (TS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EPO dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mortality rate ratio for HIV-2 relative to HIV-1
Endpoint domain: Mortality/survival
Primary endpoint: Moderate/severe sleep problem
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: ADHD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient engagement adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patients' knowledge level
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitude towards self-management at work (enjoyment)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical health quality (SF-12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of prescriptions dispensed in accordance with evidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of IIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Methacholine hyperresponsiveness prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FISI scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FIQL scales
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: GPX level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical pregnancy rate (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: levels of salivary LB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of WSL
Endpoint domain: Adverse events/effects
Primary endpoint: PaO2 levels after intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Decrease in distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: program participation rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: first-semester attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Efficacy of Pembrolizumab plus chemotherapy
Endpoint domain: Mortality/survival
Primary endpoint: Effective blood volume (BV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Elastic expansion coefficient of blood vessel (FEK)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left ventricular spray blood impedance (VER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Higher odds for providing all indicated stroke performance measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak workload
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart rate recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leisure-time activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: urge incontinence symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vaginal dryness symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in amblyopic eye visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plaque score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wakefulness after sleep onset (WASO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep and subcutaneous tissue outcomes
Primary endpoint: Latency to persistent sleep (LPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep and subcutaneous tissue outcomes
Primary endpoint: Total sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep and subcutaneous tissue outcomes
Primary endpoint: Time to ST resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean blink frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ejaculatory interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intravaginal ejaculation achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incontinence symptoms improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Adverse effects reduction
Endpoint domain: Adverse events/effects
Primary endpoint: CTFC improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: peak troponin T level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in cardiorespiratory fitness (V˙O2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood glucose concentration 2 h after oral ingestion of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Late cardiac deaths
Endpoint domain: Mortality/survival
Primary endpoint: Fewer hypokinetic chords
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: true memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: false memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Post‐Operative Morbidity Survey score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Full clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in eGFR of at least 15 ml per minute per 1.73 m²
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean ultrasonic velocity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultrasonically derived modulus of elasticity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance and normalisation of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of mammograms with abnormalities requiring follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician's Static Global Assessment score of 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of readiness for discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Agglutinin titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Intranasal bioavailability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrent instability and dislocation
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in respiratory distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: blood gas exchange
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: plasma catecholamine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: self‐recorded pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: lumen-negative peak PD values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: graft survival time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy rates/puncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of recurrent symptomatic AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: days without dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Amplitude of Glycemic Excursions (MAGE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of hypoglycemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0‐24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of WRF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Bacterial DNA copy number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Secretion of saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total hospital time
Endpoint domain: Resource use